Grottke, Oliver
Rieg, Annette
Ulmer, Florian
Hein, Marc
Funding for this research was provided by:
RWTH Aachen University
Article History
Received: 29 May 2022
Revised: 22 June 2023
Accepted: 27 June 2023
First Online: 10 August 2023
Declarations
:
: O. Grottke has received research funding from Bayer HealthCare, Biotest, Boehringer Ingelheim, CSL Behring, Novo Nordisk, Nycomed, Portola, and Octapharma. He has also received honoraria for lectures and consultancy support from Bayer HealthCare, Boehringer Ingelheim, CSL Behring, Octapharma, Pfizer, Portola, Sanofi, and Shire. A. Rieg, F. Ulmer and M. Hein declare that they have no competing interests.
: For this article no studies with human participants or animals were performed by any of the authors. Written informed consent was obtained from the patient.
: The supplement containing this article is not sponsored by industry.